Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Purpose: COVID-19-associated rhino-orbital-cerebral mucormycosis (ROCM) has reached epidemic proportion during India’s second wave of COVID-19 pandemic, with several risk factors being implicated in its pathogenesis. This study aimed to determine the patient demographics, risk factors including comorbidities, and medications used to treat COVID-19, presenting symptoms and signs, and the outcome of management. Methods: This was a retrospective, observational study of patients with COVID-19-associated ROCM managed or co-managed by ophthalmologists in India from January 1, 2020 to May 26, 2021. Results: Of the 2826 patients, the states of Gujarat (22%) and Maharashtra (21%) reported the highest number of ROCM. The mean age of patients was 51.9 years with a male preponderance (71%). While 57% of the patients needed oxygen support for COVID-19 infection, 87% of the patients were treated with corticosteroids, (21% for > 10 days). Diabetes mellitus (DM) was present in 78% of all patients. Most of the cases showed onset of symptoms of ROCM between day 10 and day 15 from the diagnosis of COVID-19, 56% developed within 14 days after COVID-19 diagnosis, while 44% had delayed onset beyond 14 days. Orbit was involved in 72% of patients, with stage 3c forming the bulk (27%). Overall treatment included intravenous amphotericin B in 73%, functional endoscopic sinus surgery (FESS)/paranasal sinus (PNS) debridement in 56%, orbital exenteration in 15%, and both FESS/PNS debridement and orbital exenteration in 17%. Intraorbital injection of amphotericin B was administered in 22%. At final follow-up, mortality was 14%. Disease stage >3b had poorer prognosis. Paranasal sinus debridement and orbital exenteration reduced the mortality rate from 52% to 39% in patients with stage 4 disease with intracranial extension (p < 0.05). Conclusion: Corticosteroids and DM are the most important predisposing factors in the development of COVID-19-associated ROCM. COVID-19 patients must be followed up beyond recovery. Awareness of red flag symptoms and signs, high index of clinical suspicion, prompt diagnosis, and early initiation of treatment with amphotericin B, aggressive surgical debridement of the PNS, and orbital exenteration, where indicated, are essential for successful outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
Roden, M. M., Zaoutis, T. E., Buchanan, W. L., Knudsen, T. A., Sarkisova, T. A., Schaufele, R. L., Sein, M., Sein, T., Chiou, C. C., Chu, J. H., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/432579 · Cited by 3,044
Cornely, O. A., Alastruey-Izquierdo, A., Arenz, D., Chen, S. C. A., Dannaoui, E., Hochhegger, B., Hoenigl, M., Jensen, H. E., Lagrou, K., Lewis, R. E., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30312-3 · Cited by 1,820
Rawson, T. M., Moore, L. S. P., Zhu, N., Ranganathan, N., Skolimowska, K., Gilchrist, M., Satta, G., Cooke, G., & Holmes, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa530 · Cited by 1,662
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India
Singh, A. K., Singh, R., Joshi, S. R., & Misra, A. (2021) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2021.05.019 · Cited by 1,102
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Yang, J.-K., Lin, S.-S., Ji, X.-J., & Guo, L.-M. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0109-4 · Cited by 1,084
Jeong, W., Keighley, C., Wolfe, R., Lee, W. L., Slavin, M. A., Kong, D. C. M., & Chen, S. C.-A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.07.011 · Cited by 1,082
Global Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 938
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Marty, F. M., Ostrosky-Zeichner, L., Cornely, O. A., Mullane, K. M., Perfect, J. R., Thompson, G. R., Alangaden, G. J., Brown, J. M., Fredricks, D. N., Heinz, W. J., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00071-2 · Cited by 704
Epidemiology and Diagnosis of Mucormycosis: An Update
Skiada, A., Pavleas, I., & Drogari-Apiranthitou, M. (2020) · Journal of Fungi · doi:10.3390/jof6040265 · Cited by 687
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 669
Song, G., Liang, G., & Liu, W. (2020) · Mycopathologia · doi:10.1007/s11046-020-00462-9 · Cited by 644
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
John, T. M., Jacob, C. N., & Kontoyiannis, D. P. (2021) · Journal of Fungi · doi:10.3390/jof7040298 · Cited by 524
Combination Polyene‐Caspofungin Treatment of Rhino‐Orbital‐Cerebral Mucormycosis
Reed, C., Bryant, R., Ibrahim, A. S., Edwards, Jr., Filler, S. G., Goldberg, R., & Spellberg, B. (2008) · Clinical Infectious Diseases · doi:10.1086/589857 · Cited by 494
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Hoenigl, M., Seidel, D., Carvalho, A., Rudramurthy, S. M., Arastehfar, A., Gangneux, J.-P., Nasir, N., Bonifaz, A., Araiza, J., Klimko, N., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00237-8 · Cited by 443
Epidemiology of Mucormycosis in India
Prakash, H., & Chakrabarti, A. (2021) · Microorganisms · doi:10.3390/microorganisms9030523 · Cited by 441
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
Hoenigl, M., Seidel, D., Carvalho, A., Rudramurthy, S. M., Arastehfar, A. A., Gangneux, J., Nasir, N., Bonifáz, A., Araiza, J., Климко, Н. Н., et al. (2022) · Kölner Universitäts PublikationsServer (Universität zu Köln) · Cited by 424
Patel, A., Kaur, H., Xess, I., Michael, J. S., Savio, J., Rudramurthy, S., Singh, R., Shastri, P., Umabala, P., Sardana, R., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.021 · Cited by 405
Self-citationA prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment
Prakash, H., Ghosh, A. K., Rudramurthy, S. M., Singh, P., Xess, I., Savio, J., Pamidimukkala, U., Jillwin, J., Varma, S., Das, A., et al. (2019) · Medical Mycology · doi:10.1093/mmy/myy060 · Cited by 389
Mucor in a Viral Land: A Tale of Two Pathogens
Sen, M., Lahane, S., Lahane, T. P., Parekh, R., & Honavar, S. G. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_3774_20 · Cited by 387
Self-citationWalsh, T. J., Gamaletsou, M. N., McGinnis, M. R., Hayden, R. T., & Kontoyiannis, D. P. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir868 · Cited by 386
Kontoyiannis, D. P., & Lewis, R. E. (2011) · Blood · doi:10.1182/blood-2011-03-316430 · Cited by 376
Commensal Fungi in Health and Disease
Limon, J. J., Skalski, J. H., & Underhill, D. M. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.002 · Cited by 336 · cited 21×
“Both the series included mucormycosis at all anatomical sites and not just ROCM.”
BackgroundInfluentialHonavar, S. G. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1165_21 · Cited by 309
Self-citationHealthcare-Associated Mucormycosis
Rammaert, B., Lanternier, F., Zahar, J.-R., Dannaoui, E., Bougnoux, M.-E., Lecuit, M., & Lortholary, O. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir867 · Cited by 282
COVID-19 and orbital mucormycosis
Sarkar, S., Gokhale, T., Choudhury, S. S., & Deb, A. K. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_3763_20 · Cited by 263
Self-citationMucormycosis: Battle with the Deadly Enemy over a Five-Year Period in India
Chander, J., Kaur, M., Singla, N., Punia, R., Singhal, S., Attri, A., Alastruey-Izquierdo, A., Stchigel, A., Cano-Lira, J., & Guarro, J. (2018) · Journal of Fungi · doi:10.3390/jof4020046 · Cited by 215
Nithyanandam, S., Jacob, M. S., Battu, R., Thomas, R. K., Correa, M. A. R., & D’Souza, O. (2003) · PubMed · Cited by 197
Rise of the phoenix: Mucormycosis in COVID-19 times
Ravani, S. A., Agrawal, G. A., Leuva, P. A., Modi, P. H., & Amin, K. D. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_310_21 · Cited by 197
Self-citationSipsas, N. V., Gamaletsou, M. N., Anastasopoulou, A., & Kontoyiannis, D. P. (2018) · Journal of Fungi · doi:10.3390/jof4030090 · Cited by 183
Combination Therapy for Mucormycosis: Why, What, and How?
Spellberg, B., Ibrahim, A., Roilides, E., Lewis, R. E., Lortholary, O., Petrikkos, G., Kontoyiannis, D. P., & Walsh, T. J. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir885 · Cited by 171
A prospective study of mucormycosis in north India: Experience from a tertiary care hospital
Bala, K., Chander, J., Handa, U., Punia, R. S., & Attri, A. K. (2015) · Medical Mycology · doi:10.1093/mmy/myu086 · Cited by 164
Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
Ellsworth, M., & Ostrosky-Zeichner, L. L. (2020) · Journal of Fungi · doi:10.3390/jof6040324 · Cited by 149
Laboratory Diagnosis of Mucormycosis: Current Status and Future Perspectives
Lackner, M., Caramalho, R., & Lass‐Flörl, C. (2014) · Future Microbiology · doi:10.2217/fmb.14.23 · Cited by 148
Mohan, A., Tiwari, P., Bhatnagar, S., Patel, A., Maurya, A. K., Dar, L., Pahuja, S., Garg, R. K., Gupta, N., Sahoo, B., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1788_20 · Cited by 88
Self-citationCOVID-19 endocrinopathy with hindsight from SARS
Narasimhan, K., Anantharaj, R., Xue, B., Yew, W. S., Velan, S. S., Karnani, N., & Leow, M. K. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00480.2020 · Cited by 82
Recent advances in the molecular diagnosis of mucormycosis
Dadwal, S., & Kontoyiannis, D. P. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1522250 · Cited by 81
Posaconazole: an emerging therapeutic option for invasive rhino‐orbito‐cerebral mucormycosis
Manesh, A., John, A. O., Mathew, B., Varghese, L., Rupa, V., Zachariah, A., & Varghese, G. M. (2016) · Mycoses · doi:10.1111/myc.12529 · Cited by 46
Orbital Exenteration: A Dilemma in Mucormycosis Presented with Orbital Apex Syndrome
Songu, M., Ünlü, H., Günhan, K., İlker, S. S., & Neşe, N. (2008) · American Journal of Rhinology · doi:10.2500/ajr.2008.22.3121 · Cited by 44
Kayina, C. A., Haritha, D., Soni, L., Behera, S. K., Nair, P. R., Gouri, M. L., Girish, K., Deeparaj, L., Maitra, S., Anand, R. K., et al. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2890_20 · Cited by 44
Newly diagnosed diabetes in patients with mild to moderate COVID-19
Sathish, T., & Anton, M. C. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.02.034 · Cited by 40
Orbital mycoses in an adult subtropical population
Lee, A. S., Lee, P. W. Y., Allworth, A. M., Smith, T. M., & Sullivan, T. J. (2019) · Eye · doi:10.1038/s41433-019-0733-3 · Cited by 38
Clinical course and outcome of patients with COVID-19 in Mumbai City: an observational study
de Souza, R., Mhatre, S., Qayyumi, B. N., Chitkara, G., Madke, T., Joshi, M., Bharmal, R. N., Asgaonkar, D., Lakhani, P., Gupta, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042943 · Cited by 24
Self-citationMarimuthu, Y., Kunnavil, R., Anil, N., Nagaraja, S. B., Satyanarayana, N., Kumar, J., & Ramya, B. (2021) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2021.1724 · Cited by 20
Cited by
COVID-19-associated fungal infections
Hoenigl, M., Seidel, D., Sprute, R., Cunha, C., Oliverio, M., Goldman, G. H., Ibrahim, A. S., & Carvalho, A. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01172-2 · Cited by 482
Let’s talk about sex characteristics—as a risk factor for invasive fungal diseases.
Egger, M., Hoenigl, M., Thompson, G. R., Carvalho, A., & Jenks, J. D. (2022) · Mycoses · doi:10.1111/myc.13449 · Cited by 82
Metadata
- Authors
- Sen, M., Honavar, S. G., Bansal, R., Sengupta, S., Rao, R., Kim, U., Sharma, M., Sachdev, M., Grover, A. K., Surve, A., Budharapu, A., Ramadhin, A. K., Tripathi, A. K., Gupta, A., Bhargava, A., Sahu, A., Khairnar, A., Kochar, A., Madhavani, A., Shrivastava, A. K., Desai, A. K., Paul, A., Ayyar, A., Bhatnagar, A., Singhal, A., Nikose, A. S., Bhargava, A., Tenagi, A. L., Kamble, A., Nariani, A., Patel, B., Kashyap, B., Dhawan, B., Vohra, B., Mandke, C., Thrishulamurthy, C., Sambare, C., Sarkar, D., Mankad, D. S., Maheshwari, D., Lalwani, D., Kanani, D., Patel, D., Manjandavida, F. P., Godhani, F., Agarwal, G. A., Ravulaparthi, G., Shilpa, G. V., Deshpande, G., Thakkar, H., Shah, H., Ojha, H. R., Jani, H., Gontia, J., Mishrikotkar, J. P., Likhari, K., Prajapati, K., Porwal, K., Koka, K., Dharawat, K. S., Ramamurthy, L. B., Bhattacharyya, M., Saini, M., Christy, M. C., Das, M., Hada, M., Panchal, M., Pandharpurkar, M., Ali, M. O., Porwal, M., Gangashetappa, N., Mehrotra, N., Bijlani, N., Gajendragadkar, N., Nagarkar, N. M., Modi, P., Rewri, P., Sao, P., Patil, P. S., Giri, P., Kapadia, P., Yadav, P., Bhagat, P., Parekh, R., Dyaberi, R., Chauhan, R. S., Kaur, R., Duvesh, R. K., Murthy, R., Dandu, R. V., Kathiara, R., Beri, R., Pandit, R., Rani, R. H., Gupta, R., Pherwani, R., Sapkal, R., Mehta, R., Tadepalli, S., Fatima, S., Karmarkar, S., Patil, S. S., Shah, S., Shah, S., Shah, S., Dubey, S., Gandhi, S., Kanakpur, S., Mohan, S., Bhomaj, S., Kerkar, S., Jariwala, S., Sahu, S., Tara, S., Maru, S. K., Jhavar, S., Sharma, S., Gupta, S., Kumari, S., Das, S., Menon, S., Burkule, S., Nisar, S. P., Kaliaperumal, S., Rao, S., Pakrasi, S., Rathod, S., Biradar, S. G., Kumar, S., Dutt, S., Bansal, S., Ravani, S. A., Lohiya, S., Rizvi, S. W. A., Gokhale, T., Lahane, T. P., Vukkadala, T., Grover, T., Bhesaniya, T., Chawla, U., Singh, U., Une, V. L., Nandedkar, V., Subramaniam, V., Eswaran, V., Chaudhry, V. N., Rangarajan, V., Dehane, V., Sahasrabudhe, V. M., Sowjanya, Y., Tupkary, Y., Phadke, Y., & and the members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group
- Venue
- Indian Journal of Ophthalmology
- Published
- 2021-06-18
- Volume
- 69
- Issue
- 7
- Pages
- 1670-1692
- ISSN
- 0301-4738 (ISSN-L)
- 1998-3689
- OpenAlex
- W3176054457
- Cited by
- 418
- References
- 44
- FWCI
- 27.10
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.